Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, and CAR-T cell therapy research.
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Long-Term Survival in Patients With Advanced Melanoma
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma
BRAF/MEK inhibitor rechallenge in advanced melanoma patients
Adjuvant treatment with anti‐ <scp>PD</scp> ‐1 in acral melanoma: A nationwide study
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?